SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — FibroGen Inc. (FGEN) on Monday reported a loss of $32.9 million in its first quarter.

On a per-share basis, the San Francisco-based company said it had a loss of 33 cents.

The biotech drug developer posted revenue of $55.9 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FGEN at https://www.zacks.com/ap/FGEN

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News